Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DermTech, Inc.DMTK · Entity 89998 | Director | June 01, 2023 | June 05, 2023 |
| Natera, Inc.NTRA · Entity 2635 | Director | June 26, 2026 | July 01, 2026 |
| VIVUS INCVVUS · Entity 151460 | Director | February 20, 2020 | February 24, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DermTech, Inc.
Report date June 01, 2023 · Filed June 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,576 |
Reported balance
After 2023-06-01 transaction · row 1
1 source rowRow 1 · 2023-06-01 · Grant · Acquired 35,714 · Balance 134,576 F1: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on June 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on June 1, 2024.
Natera, Inc.
Report date June 26, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,927 |
Ending reported balance
After 2026-06-26 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-26 · Grant · Acquired 1,571 · Balance 5,821 F1: Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 11, 2027. The RSUs will become fully vested in the event that the Issuer is subject to a change in control. F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Row 2 · 2026-06-26 · Grant · Acquired 106 · Balance 5,927 F3: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 11, 2027. The RSUs will become fully vested in the event that the Issuer is subject to a change in control.
F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.
VIVUS INC
Report date February 20, 2020 · Filed February 24, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.41 | Direct | 15,000 |
Reported balance
After 2020-02-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-02-20 · Grant · Acquired 15,000 · Balance 15,000 F1: One twelfth (1/12th) of the total number of shares underlying the option vest and become exercisable on the monthly anniversary date following June 5, 2019, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2018 Equity Incentive Plan) on the relevant vesting dates. F2: The option expires on the earlier of (a) February 20, 2027 and (b) the six (6) month anniversary of the date the reporting person ceases to be a Service Provider. |
Filing footnotes · ownership attribution and instrument terms
F1: One twelfth (1/12th) of the total number of shares underlying the option vest and become exercisable on the monthly anniversary date following June 5, 2019, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2018 Equity Incentive Plan) on the relevant vesting dates.
F2: The option expires on the earlier of (a) February 20, 2027 and (b) the six (6) month anniversary of the date the reporting person ceases to be a Service Provider.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Oxford Immunotec Global PLC
Report date March 08, 2021 · Filed March 12, 2021
Section 16 reporting ended · disclosed 2021-03-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 1
1 source rowRow 1 · 2021-03-08 · Disposition to issuer · Disposed 4,081 · Balance 0 F1: Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme"). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.65 · Expires 2026-06-28 | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-03-08 · Disposition to issuer · Disposed 7,457 · Balance 0 F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.46 · Expires 2027-06-06 | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-03-08 · Disposition to issuer · Disposed 7,457 · Balance 0 F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.49 · Expires 2028-06-19 | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-03-08 · Disposition to issuer · Disposed 7,457 · Balance 0 F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.44 · Expires 2029-06-18 | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-03-08 · Disposition to issuer · Disposed 7,457 · Balance 0 F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.40 · Expires 2023-11-22 | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-03-08 · Disposition to issuer · Disposed 7,457 · Balance 0 F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.40 · Expires 2023-11-22 | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-03-08 · Disposition to issuer · Disposed 14,914 · Balance 0 F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.86 · Expires 2024-06-12 | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-03-08 · Disposition to issuer · Disposed 7,457 · Balance 0 F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.17 · Expires 2025-06-09 | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-03-08 · Disposition to issuer · Disposed 7,457 · Balance 0 F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.96 · Expires 2030-06-24 | Direct | 0 |
Reported balance
After 2021-03-08 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-03-08 · Disposition to issuer · Disposed 9,494 · Balance 0 F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").
F2: In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price.
F3: Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2026 Filed Jul 1, 2026 00:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 106 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001230057-26-000005 · form4-06302026_080612.xml · nonDerivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,927 F3 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 26, 2026 Filed Jul 1, 2026 00:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 1,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001230057-26-000005 · form4-06302026_080612.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,821 F1 · shares: Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 11, 2027. The RSUs will become fully vested in the event that the Issuer is subject to a change in control. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 24, 2026 Filed Jun 27, 2026 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 16,530 | $250.00 | $4,132,500.00 |
DisclosureSEC source: 0001230057-26-000004 · form4-06262026_090601.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,250 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025. Read SEC document |
| April 24, 2026 Filed Apr 29, 2026 00:35 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 222 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001230057-26-000003 · form4-04282026_080414.xml · nonDerivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,780 F3 · shares: Represents the issuance of RSUs to the Reporting Person. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 24, 2026 Filed Apr 29, 2026 00:35 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 117 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001230057-26-000003 · form4-04282026_080414.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,558 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 30, 2026 Filed Feb 4, 2026 01:35 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 99 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001230057-26-000001 · form4-02032026_080211.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,441 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 12, 2025 Filed Dec 17, 2025 02:05 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 150 | $229.10 | $34,364.25 |
DisclosureSEC source: 0001230057-25-000005 · form4-12162025_091201.xml · nonDerivative · entry 5 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,342 Read SEC document |
| December 12, 2025 Filed Dec 17, 2025 02:05 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 11,987 | $228.49 | $2,738,859.28 |
DisclosureSEC source: 0001230057-25-000005 · form4-12162025_091201.xml · nonDerivative · entry 4 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,492 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.00 to $228.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2025 Filed Dec 17, 2025 02:05 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 21,910 | $227.35 | $4,981,308.61 |
DisclosureSEC source: 0001230057-25-000005 · form4-12162025_091201.xml · nonDerivative · entry 3 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,479 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.95 to $227.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2025 Filed Dec 17, 2025 02:05 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 14,372 | $226.62 | $3,256,945.27 |
DisclosureSEC source: 0001230057-25-000005 · form4-12162025_091201.xml · nonDerivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,389 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.9450 to $226.9350 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 31, 2025 Filed Dec 17, 2025 02:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 132 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001230057-25-000005 · form4-12162025_091201.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,761 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| July 25, 2025 Filed Jul 30, 2025 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 153 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-020518 · form4-07292025_090710.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,629 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 27, 2025 Filed Jul 2, 2025 01:15 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 271 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-018839 · form4-07012025_090712.xml · nonDerivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,476 F3 · shares: Represents the issuance of RSUs to the Reporting Person. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 27, 2025 Filed Jul 2, 2025 01:15 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 2,143 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-018839 · form4-07012025_090712.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,205 F1 · shares: Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 12, 2026. The RSUs will become fully vested in the event that the Issuer is subject to a change in control. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 25, 2025 Filed Apr 30, 2025 00:35 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 164 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-011553 · form4-04292025_080408.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,062 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 31, 2025 Filed Feb 5, 2025 02:15 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 133 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-003071 · form4-02042025_090209.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,898 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $22,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| October 25, 2024 Filed Oct 30, 2024 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 178 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-025716 · form4-10292024_091007.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,765 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $22,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| July 26, 2024 Filed Jul 31, 2024 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 206 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-020385 · form4-07302024_090710.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,587 F1 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $22,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 2,964 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-019068 · form4-07022024_090711.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,381 F1 · shares: Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 12, 2025. The RSUs will become fully vested in the event that the Issuer is subject to a change in control. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 26, 2024 Filed May 1, 2024 00:35 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 244 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011826 · form4-04302024_080407.xml · nonDerivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,417 F3 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $22,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 26, 2024 Filed May 1, 2024 00:35 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011826 · form4-04302024_080407.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,173 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over one year. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:45 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 93,901 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001415889-24-004268 · form4-02172024_020201.xml · derivative · entry 4 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 93,901 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The Reporting Person exercised this option as required prior to the expiration date of February 24, 2024. F5 · derivative.exercise_date: The option shares are fully exercisable. F4 · derivative.underlying_shares: The Reporting Person exercised this option as required prior to the expiration date of February 24, 2024. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:45 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 35,947 | $69.85 | $2,510,851.22 |
DisclosureSEC source: 0001415889-24-004268 · form4-02172024_020201.xml · nonDerivative · entry 3 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,685 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.53 to $70.12 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:45 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 57,954 | $69.08 | $4,003,520.27 |
DisclosureSEC source: 0001415889-24-004268 · form4-02172024_020201.xml · nonDerivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,632 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.5270 to $69.36 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:45 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 93,901 | $2.66 | $249,485.57 |
DisclosureSEC source: 0001415889-24-004268 · form4-02172024_020201.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 303 | $63.79 | $19,328.37 |
DisclosureSEC source: 0001415889-24-002001 · form4-01302024_080109.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,685 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $19,375 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| October 27, 2023 Filed Nov 1, 2023 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 454 | $42.60 | $19,340.40 |
DisclosureSEC source: 0001415889-23-014637 · form4-10312023_091006.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,382 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $19,375 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| July 28, 2023 Filed Aug 2, 2023 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 380 | $48.48 | $18,422.40 |
DisclosureSEC source: 0001415889-23-011688 · form4-08012023_090808.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,928 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $18,427.20 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 30, 2023 Filed Jul 6, 2023 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantStock Option (right to buy) · Derivative | 4,255 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001415889-23-010853 · form4-07052023_090729.xml · derivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,255 Underlying: Common Stock · 4,255 shares Expires 2033-06-08 F3 · derivative.exercise_date: The option shares shall vest and become exercisable in full on June 9, 2024. The option shares will become fully vested and exercisable in the event that the Issuer is subject to a change in control. Read SEC document |
| June 30, 2023 Filed Jul 6, 2023 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 2,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-010853 · form4-07052023_090729.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,548 F1 · shares: Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 9, 2024. The RSUs will become fully vested in the event that the Issuer is subject to a change in control. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:30 UTC | DermTech, Inc. DMTK · Entity 89998 | GrantCommon Stock | 35,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034603 · doc4.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,576 F1 · shares: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on June 1, 2024. Read SEC document |
| May 25, 2023 Filed May 27, 2023 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionRestricted Stock Unit · Derivative | 3,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008885 · form4-05262023_090510.xml · derivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,534 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU vested in full on May 25, 2023. F2 · derivative.expiration_date: The RSU vested in full on May 25, 2023. Read SEC document |
| May 25, 2023 Filed May 27, 2023 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 3,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-008885 · form4-05262023_090510.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 14, 2023 Filed Apr 19, 2023 00:10 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 331 | $54.73 | $18,115.63 |
DisclosureSEC source: 0001415889-23-006660 · form4-04182023_080417.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,264 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $18,125 for service on the Issuer's Board of Directors. The RSUs were fully-vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 13, 2023 Filed Jan 19, 2023 02:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 453 | $40.01 | $18,124.53 |
DisclosureSEC source: 0001415889-23-001142 · form4-01182023_090106.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,933 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $18,125 for service on the Issuer's Board of Directors. The RSUs were fully-vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| October 14, 2022 Filed Oct 19, 2022 01:08 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 399 | $45.42 | $18,122.58 |
DisclosureSEC source: 0001415889-22-010701 · form4-10182022_091028.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,480 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $18,125 for service on the Issuer's Board of Directors. The RSUs were fully-vested at the time of issuance. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| July 08, 2022 Filed Jul 13, 2022 01:05 UTC | Natera, Inc. NTRA · Entity 2635 | GrantRestricted Stock Unit · Derivative | 499 | $36.31 | $18,118.69 |
DisclosureSEC source: 0001415889-22-007649 · form4-07122022_090732.xml · derivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499 Underlying: Common Stock · 499 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: The RSUs were issued to the Reporting Person in lieu of retainer fees of $18,125 for service on the Issuer's Board of Directors. F3 · derivative.exercise_date: The RSUs are fully vested and may be exercised at any time. F3 · derivative.expiration_date: The RSUs are fully vested and may be exercised at any time. Read SEC document |
| July 08, 2022 Filed Sep 3, 2022 00:05 UTC Amendment | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009320 · form4a-09022022_080916.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,081 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $18,125 for service on the Issuer's Board of Directors. The previously filed Form 4 inadvertently reported the transaction on Table II. The RSUs were fully-vested at the time of issuance and should have been reported on Table I as reflected in this amendment. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 01:06 UTC | Natera, Inc. NTRA · Entity 2635 | GrantStock Option (right to buy) · Derivative | 7,068 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0001415889-22-006012 · form4-06012022_090649.xml · derivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,068 Underlying: Common Stock · 7,068 shares Expires 2032-05-25 F3 · derivative.exercise_date: The option shares shall vest and become exercisable in full on May 25, 2023. The option shares will become fully vested and exercisable in the event that the Issuer is subject to a change in control. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 01:06 UTC | Natera, Inc. NTRA · Entity 2635 | GrantRestricted Stock Unit · Derivative | 3,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006012 · form4-06012022_090649.xml · derivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,534 Underlying: Common Stock · 3,534 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU shall vest in full on May 25, 2023. The RSU will become fully vested in the event that the Issuer is subject to a change in control. F2 · derivative.expiration_date: The RSU shall vest in full on May 25, 2023. The RSU will become fully vested in the event that the Issuer is subject to a change in control. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:15 UTC | DermTech, Inc. DMTK · Entity 89998 | GrantCommon Stock | 26,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-032991 · doc4.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,862 F1 · shares: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on May 26, 2023. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:46 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionRestricted Stock Unit · Derivative | 1,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005862 · form4-05272022_090536.xml · derivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,307 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU vested in full on May 25, 2022. F2 · derivative.expiration_date: The RSU vested in full on May 25, 2022. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:46 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 1,307 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-005862 · form4-05272022_090536.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 09, 2022 Filed May 12, 2022 00:02 UTC | DermTech, Inc. DMTK · Entity 89998 | PurchaseCommon Stock | 20,000 | $6.86 | $137,298.00 |
DisclosureSEC source: 0001209191-22-028411 · doc4.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,832 Read SEC document |
| May 09, 2022 Filed Jun 1, 2022 00:14 UTC Amendment | DermTech, Inc. DMTK · Entity 89998 | PurchaseCommon Stock | 20,000 | $6.86 | $137,298.00 |
DisclosureSEC source: 0001209191-22-032990 · doc4a.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,382 F1 · balance_after: On May 11, 2022, the reporting person filed a Form 4 which inadvertently reported that, following his purchase of 20,000 shares of common stock of the issuer, he beneficially owned 72,832 shares of common stock of the issuer. In fact, as reported by this amendment, the reporting person beneficially owned 72,382 shares of common stock of the issuer at such time. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 02:30 UTC Amendment | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 44,503 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001415889-21-005123 · form4a-11092021_061106.xml · derivative · entry 6 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,901 Underlying: Common Stock · 44,503 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 02:30 UTC Amendment | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 400 | $120.24 | $48,096.00 |
DisclosureSEC source: 0001415889-21-005123 · form4a-11092021_061106.xml · nonDerivative · entry 5 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,275 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.19 to $120.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 02:30 UTC Amendment | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 2,832 | $119.62 | $338,758.18 |
DisclosureSEC source: 0001415889-21-005123 · form4a-11092021_061106.xml · nonDerivative · entry 4 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,675 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.16 to $120.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 02:30 UTC Amendment | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 2,100 | $118.79 | $249,454.80 |
DisclosureSEC source: 0001415889-21-005123 · form4a-11092021_061106.xml · nonDerivative · entry 3 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,507 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.12 to $119.0250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 02:30 UTC Amendment | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 39,171 | $117.13 | $4,587,993.47 |
DisclosureSEC source: 0001415889-21-005123 · form4a-11092021_061106.xml · nonDerivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,607 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.00 to $117.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · price: The prior Form 4 report filed on November 9, 2021 inaccurately reflected $17.1273 as the weighted average sales price instead of $117.1273. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.